Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,363
Ph III recruiting: 292
Growth YoY: +13%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,000)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06936527	XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation(XS-03-II201)	enrolling by invitation	Phase 1 / Phase 2	102	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.INDUSTRY	1	Sep 25, 2026	clinicaltrials
NCT07683949	Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine(LENCAP-CRC)	enrolling by invitation	Phase 1 / Phase 2	93